Biomarkers are molecules of biological processes that help in both the diagnosis of human
diseases and in follow-up assessments of therapeutic responses. Biomarkers can be …

(1) Background: Immunological laboratory testing is known to be complex, and it is usually
performed in tertiary referral centers. Many criticalities affect diagnostic immunological …

Introduction Finding a non-invasive and repeatable tool has been recommended to make an
accurate diagnosis of Alzheimer's disease (AD) and Parkinson's disease (PD). Methods 70 …

Introduction: Spanning the three stages of the Alzheimer's disease (AD) continuum, amyloid-
beta (Aβ40 and Aβ42) oligomers (AβO's) and tau protein constitute a set of biomarkers …

The identification of reliable biomarkers in biological fluids is paramount to optimizing the
diagnosis of Alzheimer's disease (AD). Measurement of Aβ42, t-tau, and p-tau in …

Over 65 million people suffer from recurrent, unprovoked seizures. The lack of validated
biomarkers specific for myriad forms of epilepsy makes diagnosis challenging. Diagnosis …

Nano-MoS 2 exhibit oxidoreductase-like activities, and has been shown to effectively
eliminate excessive intracellular ROS and inhibit Aβ aggregation, thus demonstrating …

Background Sleep disturbances are highly prevalent in patients with age-related
neurodegenerative diseases, which severely affect cognition and even lead to accumulated …

Introduction Monoclonal antibodies targeting amyloid-β are the first disease-modifying
treatments for Alzheimer disease to have received FDA-approval. There are three different …

Dopaminergic neurons are constantly threatened by the thin boundaries between functional
α-synuclein (AS) structural disorder and pathogenic aggregation, and between dopamine …